
ALT Graphical data showing changes in liver fat content as measured by MRI-PDFF. The top graph (A) indicates "Percent Change in Liver Fat by MRI-PDFF over Time." It features a pooled placebo group (gray line) and four treatment groups showing different doses of CIDEBsiRNA (15 mg, 30 mg, 60 mg, and 600 mg) (blue lines). The bottom graph (B) illustrates "Absolute Values of Liver Fat by MRI-PDFF over Time." TSimilar to graph (A), the treatment groups are plotted against the pooled placebo with the same dosages over a 36-week period. A table at the bottom displays the number of participants for each group.

ALT Bar chart showing the frequency of monthly seizures for Patients 1, 2, and 3 before and after chemogenetic neuromodulation treatment. Orange bars indicate the number of seizures before treatment: Patient 1 has 4.5, Patient 2 has 4.0, and Patient 3 has 4.5. Purple bars indicate the number of seizures after treatment: Patient 1 has 0.5, Patient 2 has 0, and Patient 3 has 0.5. The vertical axis represents the number of seizures per month.




































